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Abstract
Background: In Switzerland, the French-speaking region has an organized breast cancer (BC) screening program; in
the German-speaking region, only opportunistic screening until recently had been offered. We evaluated factors
associated with attendance to breast cancer screening in these two regions.
Methods: We analyzed the data of 50–69 year-old women (n = 2769) from the Swiss Health Survey 2012. Factors of
interest included education level, place of residence, nationality, marital status, smoking history, alcohol consumption,
physical activity, diet, self-perceived health, history of chronic diseases and mental distress, visits to medical doctors and
cervical and colorectal cancer screening. Outcome measures were dichotomized into ≤2 years since most recent
mammography versus >2 years or never.
Results: In the German- and French-speaking regions, mammography attendance within the last two years was 34.9 %
and 77.8 %, respectively. In the French region, moderate alcohol consumption (adjusted OR 2.01, 95 % CI 1.28–3.15)
increased screening attendance. Compared to those with no visit to a physician during the recent year, women in
both regions with such visits attended statistically significantly more often BC screening (1–5 times vs. no visit: German
(adjusted OR 3.96, 95 % CI 2.58–6.09); French: OR 7.25, 95 % CI 4.04–13.01). Non-attendance to cervical screening had a
negative effect in both the German (adjusted OR 0.44, 95 % CI 0.25–0.79) and the French region (adjusted OR 0.57,
95 % CI 0.35–0.91). The same was true for colorectal cancer screening (German (adjusted OR 0.66, 95 % CI 0.52–0.84);
French: OR 0.52, 95 % CI 0.33–0.83). No other factor was associated with BC screening and none of the tests of
interaction comparing the two regions revealed statistically significant results.
Conclusion: The effect of socio-demographic characteristics, lifestyle, health factors and screening behavior other than
mammography on non-attendance to BC screening did not differ between the two regions with mainly opportunistic
and organized screening, respectively, and did not explain the large differences in attendance between regions. Other
potential explanations such as public promotion of attendance for BC screening, physicians’ recommendations
regarding mammography participation or women’s beliefs should be further investigated.
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Background
Opportunistic mammography is a screening tool used by
women on their own initiative or following the advice of
their gynecologist or general practitioner. Organized
breast cancer (BC) screening is a free service offered
periodically to asymptomatic women aged e.g. 50–69
years depending on the recommendations of various
countries. These screening programs are performed
according to guidelines for quality assurance [1, 2]. In
Switzerland, organized BC screening programs coexist
with opportunistic mammography screening. The Federal
Office of Social Insurance decided in 1999 to reimburse
biennial mammography screening for women aged
50 years and above through the Swiss compulsory health
insurance system, when performed within a quality-
assured program [3]. In 2012, the whole French-speaking
region of Switzerland was covered by an organized BC
screening program. The German-speaking region of
Switzerland, on the other hand, started introducing
organized screening programs in 2010 in the canton
of Thurgovia, 2011 in the cantons of St. Gallen and
Grisons, 2013 in the canton of Berne, and 2014 in
the canton of Basel-City but not in the rest of the
German speaking cantons. Thus, when the 2012 Swiss
Health Survey (SHS) was carried out, mainly oppor-
tunistic BC screening existed in the German-speaking
part of Switzerland [4].
In previous studies, non-attendance to BC screening
was associated with lifestyle factors such as smoking [5],
lower physical activity [6], and alcohol abstinence [7]. In
addition, health-related factors such as poor self-
perceived health [7], serious psychological distress [8],
and non-attendance to cervical cancer screening were
associated with non-attendance [9]. Socio-demographic
factors such as lower level of education and lower occu-
pational class [10], living without partner [11, 12], and
nationality/migration status [13] may be of importance.
The few studies that considered this topic found evi-
dence that factors associated with non-attendance to
mammography screening might differ between oppor-
tunistic and organized BC screening programs [14, 15].
In a previous analysis of Swiss data on the association
between body mass index (BMI) and BC screening
attendance, we observed a higher attendance of over-
weight women overall and of women from the
German-speaking region, but not of women from the
French-speaking region [16]. Data on factors associ-
ated with non-attendance to BC screening according
to the type of screening practices are not available in
Switzerland and are scarce in other countries.
The aim of the present study was to evaluate further
factors that were associated with non-attendance to BC
screening according to the main types of screening prac-
tices (opportunistic or organized) in two regions of
Switzerland. The study sample allowed evaluating vari-
ous socio-demographic, life-style and health factors in
relation to women who do not adhere to mammography
screening. In many studies, data on non-attenders are
not available. Data from Switzerland is of particular
interest, since both types of screening are available sim-
ultaneously in a single country, and not-as is usually the
case–one screening type being replaced by another.
All analyses were based on data of the Swiss Health
Survey (SHS) 2012, and were restricted to 50–69 year-
old women, the main target group for BC screening in
Switzerland [3].
Methods
Study population and design
For the present analysis data of the cross-sectional 2012
SHS conducted by the Swiss Federal Statistical Office
[17] (Legal basis: Swiss Statistics, Ordinance of the Con-
duct of Federal statistical Surveys of 30 June 1993) were
used. This survey was comprised of participants ran-
domly selected to represent the Swiss permanent popu-
lation, i.e. Swiss citizens and foreigners with a legal work
permit of both sexes aged 15 years and older. Partici-
pants were selected from the resident population living
in a private household based on registries of inhabitants.
Individuals living in collective households such as nurs-
ing homes, military bases, prisons, monasteries, boarding
schools, hospitals, hotels etc. were not included. Of a
sample of 41,008 individuals, a total of 21,597 agreed to
participate in the survey (participation rate 54 %). The
level of representativeness of the sample was corrected
with appropriate weighting factors from the telephone
interview. All individuals were interviewed by telephone
(see below “statistical analyses”). Furthermore, all partici-
pants were invited to complete a written questionnaire.
Only German-, French- or Italian-speaking individuals
were included in the survey.
A total of 11,314 women participated in the SHS 2012.
Of these, 3,614 women (31.9 %) were 50–69 years old.
After excluding women with missing information on BC
screening (n = 469) and women living in the Italian re-
gion of Switzerland (n = 247), our sample consisted of
2,898 women. In addition, we excluded women with
missing information on demographics (n = 18), on life-
style variables (n = 39), on chronic diseases or other
screening tests (n = 72). Our final dataset consisted of
2,769 participants.
Measurements
Outcome measure: BC screening status was calculated
based on self-reported information on the last BC
screening date and then dichotomized in ≤2 years since
most recent mammography versus >2 years or never.
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Explorative variables: For socio-demographic variables
we included educational level (low: compulsory education
or less, middle: secondary education vs. high: tertiary edu-
cation), nationality (Non-Swiss vs. Swiss), area of residence
(rural vs. urban), and marital status (single, widowed, di-
vorced, separated, dissolved partner vs. married, registered
partnership). Lifestyle factors comprised smoking status
(current smoker, former smoker vs. women who have
never smoked), hazardous chronic alcohol consumption
(≥20 g ethanol daily, <20 g vs. less than once a month or
none) [18], physical activity (≥150 min per week vs. less)
[19], attention to diet (yes vs. no), and as a potential
confounder, body mass index (BMI) categorized into
underweight (BMI <18.5 kg/m2), normal weight (BMI
18.5–24.9 kg/m2), overweight (BMI 25.0–29.9 kg/m2),
and obesity (BMI ≥30 kg/m2). Health-related factors
included chronic diseases (self-reported ongoing dis-
eases or health problems lasting for at least 6 months
or expected to last a further 6 months), self-perceived
health status (fair, poor, very poor vs. very good,
good), visits to a physician within the recent year (no,
1–5, 6–10, > 10 times), psychological distress measured by
the 5-Item Mental Health Index (MHI-5) (high, moderate,
vs. low), cervical cancer screening with the Papanicolaou
test (≤3 years since most recent screening vs. >3 years or
never), and colorectal cancer screening with colonoscopy
(yes [ever] vs. no [never]).
In addition, the question “Who prompted you to at-
tend to this mammography (“own initiative”, “following
the recommendation of a medical doctor”, “in the con-
text of a screening program”)” was evaluated.
In the Swiss Health Survey, the entire study sample
comprised the German-, French- and Italian-speaking
parts of Switzerland, the language regions being defined
by the language of the municipality of the study partici-
pant’s residence. In the present study, we included the
German- and the French-speaking regions and com-
pared them with each other.
Statistical analyses
We evaluated potential differences of attendance to BC
screening in the German-speaking region with mainly
opportunistic screening and in the French-speaking
region of Switzerland with population based programs
depending on socio-demographics, lifestyle and health-
related factors as well as non-attendance to screening
other than mammography.
In our analyses, we used two logistic regression
models. Model 1 was unadjusted and model 2 was
adjusted for all other demographic, lifestyle and health
factors as shown in Table 1, with the exception of cervical
and colorectal cancer screening.
Tests for interaction were done using the cross-
product terms of each of the exposure variables
(demographics, lifestyle and health factors) with the di-
chotomized region of Switzerland (German vs. French);
this interaction term was evaluated using the Wald test.
P-values <0.05 were considered statistically significant.
Sampling weights of the telephone interviews were
provided by the Swiss Federal Statistical Office (SFSO)
and applied to the data of the present analyses to calcu-
late descriptive characteristics (percentages) and to con-
duct logistic regression analyses. The sampling weights
include a comparison with the permanent 2012 Swiss
population with regard to sex, age, geographic region
and nationality (Swiss vs. others). All calculations and
analyses were performed with STATA/SE, version 13
(StataCorp, College Station, Texas).
Results
Table 1 summarizes socio-demographic characteristics,
lifestyle and health factors, and screening behavior other
than mammography of the 1938 eligible women of the
German-speaking region and of the 831 women of the
French-speaking region of Switzerland participating in
the 2012 SHS. Of the German-speaking women, higher
percentages reached the recommendations for physical
activity (76.2 vs. 60.3 %), paid attention to their diet
(86.6 vs. 64.8 %), declared themselves to be in good
health (81.1 vs. 71.4 %) and had a cervical cancer screen-
ing test (90.8 vs. 78.3 %) compared to French-speaking
women.
Table 2 shows that in the German-speaking region of
Switzerland with its mainly opportunistic BC screening,
28.8 % of the 50–69 year-old women never had a BC
screening examination, 34.9 % had one within the past
two years, and 36.3 % had a mammography more than
two years ago. The corresponding values in the French-
speaking region, with population based BC screening
programs, were 7.3 %, 77.8 %, and 15.0 %. Of the women
who attended BC screening in the German-speaking re-
gion, 16.8 % did it on their own initiative, 73.1 %
followed the recommendation of a medical doctor, and
10.1 % in the context of a screening program. In the
French-speaking region, the corresponding values were
8.5 %, 36.5 % and 55.1 %, respectively.
Associations between socio-demographic characteris-
tics, lifestyle and health-related factors, screening behav-
ior other than mammography, and BC screening
attendance are presented separately for the two regions
in Table 3. In the German-speaking region, BC screening
attendance was significantly less common among women
not adhering to cervical cancer screening (adjusted OR
0.44, 95 % CI 0.25–0.79) and colonoscopy (adjusted OR
0.66, 95 % CI 0.52–0.84). In the French-speaking region,
moderate alcohol consumption (adjusted OR 2.01, 95 %
CI 1.28–3.15) was associated with significantly increased
attendance to BC screening. As in the German-speaking
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Table 1 Baseline characteristics (socio-demographic, lifestyle/health factors, and screening behavior other than mammography) in
50–69 year-old women: Swiss Health Survey 2012a
German region French region
Women, n 1938 831
Age, mean 58.5 59.1
% %
Educational level High 19.4 24.9
Middle 66.5 56.1
Low 14.1 19.0
Nationality Swiss 89.9 84.7
Non-Swiss 10.1 15.3
Place of residence Urban 71.1 74.5
Rural 28.9 25.5
Marital status married/registered partnership 66.0 59.4
Single, divorced/dissolved partnership, separated, widowed 34.0 40.6
BMI Underweight (BMI < 18.5 kg/m2) 3.6 4.0
Normal weight (BMI 18.5–24.9 kg/m2) 55.8 58.1
Overweight (BMI 25–29.9 kg/m2) 27.5 27.8
Obesity (BMI≥ 30 kg/m2) 13.1 10.2
Smoking status Never smoker 50.9 44.1
Ex-smoker 25.7 30.5
Current smoker 23.4 25.4
Alcohol Never 27.6 33.6
<20 g ethanol per day 68.5 60.0
≥20 g ethanol per day 4.0 6.4
Physical activity ≥150 min. per week 76.2 60.3
<150 min. per week 23.7 39.7
Attention to diet Yes 86.6 64.8
No 13.4 35.2
Self-perceived health Good, very good 81.1 71.4
Fair, poor, very poor 18.9 28.6
Chronic diseaseb No 57.0 59.5
Yes 43.0 40.5
Psychological distress Low 82.8 73.3
Moderate 12.0 18.3
High 4.9 8.4
Visits to a physician within the recent year no 16.5 10.7
1 to 5 times 62.8 66.4
6 to 10 times 12.6 13.9
>10 times 7.8 9.1
Cervical cancer screening Yes 90.8 78.3
No 9.2 21.7
Colorectal cancer screening Yes 36.0 35.9
No 64.0 64.1
a all proportions are weighted according the Swiss general population, except n
b self-reported ongoing diseases or health problems lasting for at least 6 months or expected to last further 6 months
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region, low attendance to cervical screening and colonos-
copy was statistically significantly associated with a lower
attendance to BC screening (adjusted OR 0.57, 95 % CI
0.35–0.91 and OR 0.52, 95 % CI 0.33–0.83). Compared to
those with no visit to a physician during the recent year,
women in both regions with such visits attended statisti-
cally significantly more often BC screening (1–5 times vs.
no visit: German (OR 3.96, 95 % CI 2.58–6.09); French:
OR 7.25, 95 % CI 4.04–13.01). With the exception of the
thus far mentioned associations with BC screening, none
of the other socio-demographic and lifestyle factors (edu-
cation, living in urban/rural areas, nationality, marital sta-
tus, smoking status, attention to diet and physical activity,
and health issues, characterized by self-perceived health,
chronic disease status and mental distress) was statistically
significantly associated with mammography use, in both
the German and the French-speaking regions. Further-
more, none of the tests of interaction comparing each sin-
gle explorative variable with the two regions revealed a
statistically significant result.
Discussion
The participation rate of 77.8 % in the French-speaking
region of Switzerland lies within the range of other
European countries’ screening uptake of 55 to 90 % [20].
The much lower mammography attendance in the
German-speaking region of Switzerland (34.9 %) con-
firms previous observations that women are more likely
to adhere to BC screening in countries with screening
programs than in those with opportunistic screening
[15, 21]. Factors associated with non-attendance to BC
screening might differ between opportunistic and orga-
nized BC screening programs [12, 14, 15] and the ques-
tion arises whether organized screening programs
“rescue” distinct subgroups of women who fall through
the opportunistic screening net? In the present study, we
did not find any socio-demographic, lifestyle or health
factors, which could explain the large difference in BC
screening attendance between the French- and the
German-speaking regions of Switzerland. None of the
interaction terms were statistically significant.
In contrast to previous observations demonstrating
that a socio-economic gradient is evident in BC screen-
ing attendance in opportunistic but not in population-
based programs [14], in the present study, neither at-
tendance to opportunistic nor organized BC screening
were associated with educational level, nationality, living
in urban or rural areas or marital status. Previous studies
observed that women with higher educational levels re-
ported greater screening participation [11, 22], although
not consistently so [23–25]. It should be noted that in
Switzerland, all residents are obliged by law to have a
health insurance, thus, BC screening costs are basically
covered [26]. This might explain why education, as po-
tential indicator of the women’s socioeconomic status,
was not associated with BC screening attendance in the
present study. In many studies [11, 27, 28], marital sta-
tus was associated with higher attendance to BC screen-
ing. Partners seem to encourage each other towards
health conscious behaviors [29]. A survey carried out in
Geneva, Switzerland, found that men had more favorable
attitudes towards BC screening than women [30]. Living
with a partner, but not being married or registered
(registration is in Switzerland only an option for couples
of the same sex), is considered in the Swiss Health
Survey as being single. This may explain why we did not
observe an association between marital status and BC
screening attendance.
In our study, additional socio-demographic factors
such as nationality and living in a rural or urban area
also had no effect on screening attendance rates in both
regions. Lower screening participation in urban areas
has previously been reported from various European
countries [25, 31, 32]. The different demographic com-
position of urban and rural areas in relation to migrants,
education and economic level of the inhabitants may
Table 2 Attendance to mammography in the German- and French-speaking regions of Switzerland in 50–69 years-old women:
Swiss Health Survey 2012a
German region French region
Women, n 1938 831
% %
Mammography Never 28.8 7.3
Within the last 2 years 34.9 77.8
More than 2 years ago 36.3 15.0
Who prompted you to attend to this mammography?
Own initiative 16.8 8.5
Following the recommendation of a medical doctor 73.1 36.5
In the context of a screening program 10.1 55.1
aall proportions are weighted according to the Swiss general population, except n
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Table 3 Associations of mammography attendancea with socio-demographic, lifestyle/health factors, and screening behavior other than mammography in 50-69 years-old
women: Swiss Health Survey 2012b
German region French region
unadjusted multivariable adjustedc unadjusted multivariable adjustedc
OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI P-Interaction
Educational level High 1 1 1 1
Middle 1.27 (0.94-1.72) 1.17 (0.85-1.60) 1.02 (0.63-1.63) 0.85 (0.50-1.44)
Low 1.16 (0.75-1.80) 1.08 (0.68-1.71) 0.86 (0.48-1.54) 0.60 (0.32-1.12) 0.208
Nationality Swiss 1 1 1 1
Non-Swiss 0.95 (0.59-1.51) 0.91 (0.57-1.46) 1.32 (0.70-2.49) 1.41 (0.73-2.73) 0.360
Place of residence Urban 1 1 1 1
Rural 1.14 (0.88-1.47) 1.16 (0.88-1.51) 0.86 (0.57-1.29) 0.96 (0.60-1.52) 0.255
Marital status married / registered partnership 1 1 1 1
Single, divorced / dissolved partnership,
separated, widowed
0.78 (0.61-1.01) 0.82 (0.63-1.06) 0.77 (0.53-1.13) 0.76 (0.51-1.14) 0.808
Smoking status Never smokers 1 1 1 1
Ex-smoker 1.33 (1.01-1.74) 1.28 (0.96-1.70) 1.17 (0.74-1.86) 0.97 (0.59-1.59)
Current smokers 0.87 (0.64-1.17) 0.92 (0.67-1.26) 0.76 (0.49-1.18) 0.73 (0.45-1.18) 0.399
Alcohol Never 1 1 1 1
< 20 g ethanol per day 1.19 (0.92-1.55) 1.21 (0.92-1.59) 1.86 (1.24-2.77) 2.01 (1.28-3.15)
≥ 20 g ethanol per day 0.86 (0.49-1.52) 0.94 (0.53-1.67) 1.00 (0.50-2.01) 0.98 (0.45-2.11) 0.270
Physical activity ≥ 150 min. per week 1 1 1 1
< 150 min. per week 0.88 (0.67-1.15) 0.91 (0.68-1.21) 0.79 (0.54-1.14) 0.73 (0.49-1.09) 0.355
Attention to diet Yes 1 1 1 1
No 0.86 (0.60-1.22) 1.01 (0.70-1.44) 0.81 (0.55-1.19) 1.04 (0.69-1.56) 0.565
Self-perceived health Good, very good 1 1 1 1
Fair, poor, very poor 1.25 (0.92-1.70) 1.08 (0.75-1.55) 1.81 (1.17-2.80) 1.66 (0.98-2.81) 0.205
Chronic diseased No 1 1 1 1
Yes 1.24 (0.99-1.57) 0.90 (0.69-1.17) 1.60 (1.09-2.36) 1.13 (0.72-1.77) 0.390
Psychological distress Low 1 1 1 1
Moderate 1.11 (0.78-1.59) 1.03 (0.72-1.47) 1.32 (0.83-2.10) 1.16 (0.69-1.94)
High 0.85 (0.47-1.53) 0.70 (0.38-1.30) 1.36 (0.69-2.69) 1.33 (0.61-2.86) 0.219
Visits to a physician within the recent year no 1 1 1 1
1-5 times 4.02 (2.64-6.11) 3.96 (2.58-6.09) 7.54 (4.31-13.17) 7.25 (4.04-13.01)
6 to 10 times 4.31 (2.57-7.21) 4.26 (2.49-7.30) 6.71 (3.35-13.46) 5.51 (2.60-11.68)
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Table 3 Associations of mammography attendancea with socio-demographic, lifestyle/health factors, and screening behavior other than mammography in 50-69 years-old
women: Swiss Health Survey 2012b (Continued)
> 10 times 6.43 (3.72-11.13) 7.03 (3.88-12.73) 6.14 (2.69-13.98) 6.07 (2.54-14.52) 0.976
Cervical cancer screening Yes 1 1 1 1
No 0.38 (0.21-0.69) 0.44 (0.25-0.79) 0.44 (0.29-0.67) 0.57 (0.35-0.91) 0.786
Colorectal cancer screening Yes 1 1 1 1
No 0.56 (0.44-0.71) 0.66 (0.52-0.84) 0.43 (0.28-0.65) 0.52 (0.33-0.83) 0.235
amammography screening adherence defined by participation within the last 2 years
bweighted according the Swiss general population
cadjusted for all factors shown in Table 1, except cervical cancer and colonoscopy screening
dself-reported ongoing disease or health problem lasting for at least 6 months or expected to last further 6 months
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contribute to such differences [32]. Participation to the
Swiss Health Survey was limited to German-, French- or
Italian-speaking individuals. Thus, the group of immi-
grants in the present study is restricted to those who
speak German, French or Italian. It does therefore not
reflect reality in Switzerland in relation to the various
immigrant groups living in this country, and may have
excluded minorities prone to non-attendance of BC
screening [11, 33]. Using more detailed data of the 2002
SHS, attendance to BC screening was higher in Swiss
women than in women from Italy, former Yugoslavia,
Portugal and Spain living in Switzerland [34].
In relation to lifestyle factors, represented by smoking
habits, alcohol intake, physical activity and attention to
diet, only moderate alcohol consumption in the French-
speaking region showed an association with BC screen-
ing; however, no statistically significant interactions be-
tween the two regions were observed. There is some
evidence from other studies that former smokers have a
higher attendance to BC screening [35, 36], but many
previous studies failed to distinguish between former
smokers and those who had never smoked. As Vander
Weg [36] pointed out, former smokers may see them-
selves with a higher cancer risk due to their smoking
habits in the past and, therefore, may be more motivated
to adhere to screening recommendations than non-
smokers. The findings of lower rates of mammography
among current smokers, which have been rather consist-
ently shown in other studies [7, 35, 36], were not con-
firmed in the present study and in another survey [22].
In our study, alcohol consumption had no effect on
the rates of having had BC screening with the exception
of higher BC screening attendance of women from the
French-speaking region who reported drinking moderate
amounts of alcohol. Results from other studies [7, 28]
indicate a J-shaped association between alcohol con-
sumption and BC screening use, where both abstainers
and heavy drinkers have lower attendance than women
drinking modest amounts. The absence of an association
between high and low alcohol intake and mammography
attendance in our study may be due to information bias
and a lower participation rate of heavy drinkers in re-
search studies [7, 37].
In relation to physical activity, our findings are not in
line with the results of previous studies, in which non-
attendance to BC screening was associated with lower
leisure time physical activity [7]. There are too few stud-
ies analyzing the association between nutritional habits
and BC screening attendance to come to a meaningful
conclusion [38, 39].
Impaired overall health and more frequent contact
with medical doctors, respectively, on the other hand,
may have implications for BC screening. Studies have
shown that factors such as diabetes, cognitive decline,
and depression might negatively affect the receipt of
cancer screening [8, 22, 28]. The presence of several
comorbid conditions might increase the opportunity of
receiving cancer screening or diagnosis, however, be-
cause of more frequent contact with medical doctors.
This could be an explanation for the positive association
observed between visits to a physician (compared to
none) and higher attendance to BC screening in the
present and other studies [40].
Schumacher et al. [22] observed in their Education
and Research Towards Health study that those women
who had had other screening tests (cervical and colorec-
tal cancer screening) were much more likely to have re-
ceived mammography in the past two years. This was
true for opportunistic and organized screening, as in the
present study. Similar results were seen for organized
BC screening in a study carried out in Geneva [41]. Indi-
viduals who participate in multiple cancer screenings may
be more health-conscious, and/or more knowledgeable
about cancer screening tests than those who do not
[9, 28, 42]. Those with low attendance to screening
tests, on the other hand, may be more critical about
the benefits of the screening, including anxiety related
to false positive results [43] and inaccurate knowledge
and negative mammography beliefs such as that mam-
mography may be harmful, is only needed when symp-
toms are present, is not necessary, is painful, etc. [42].
Study strengths and limitations
One strength of our study is the large representative
sample of individuals 15 years and older living in
Switzerland, allowing for limitation of our analyses to
women aged 50–69 years. This study also has several
limitations. It is a cross-sectional survey, thus, causality
cannot be inferred. In addition, data were self-reported.
Women, for example, tend to overestimate their attend-
ance to cancer screening according to the recommenda-
tions [44]. This could result in reporting and/or recall
biases. Furthermore, 46 % of eligible subjects did not
participate in the SHS survey. However, we hypothesize
that with respect to mammography attendance rates our
survey cohort represents the general population very
well because the attendance to the mammography
screening programs in the French-speaking cantons were
similar to the official data of Swiss Cancer Screening in
2011 (51 %) [4]. In addition, the use of weighting factors
allowed for the extrapolation of the results in relation to
age, gender, region and nationality from the sample to
the total population living in Switzerland [17]. Further-
more, attendance to opportunistic or organized screening
was not clear-cut in the present study, i.e. in the German-
and in the French-speaking regions, 10.1 % and 55.1 %,
respectively, had a mammography in the context of a
screening program, i.e. in the German-speaking region
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16.8 % attended mammography on their own initiative,
73.1 % followed the advice of a medical doctor (French-
speaking region: 8.5 % and 36.5 %, respectively). Women
with a personal or family history of breast diseases might
undergo regular radiologic breast imaging and thus, do
not attend a screening BC program. In particular, women
who had mammography in previous years in private radi-
ology practices might prefer to continue these examina-
tions in this trusted setting.
Finally, other factors that may be significant determi-
nants of BC screening utilization have not been recorded
in the current study [20, 21, 42, 45], such as promotion
of BC screening by the government, cancer leagues,
medical organizations and lay press. Furthermore, per-
sonal or family BC history, knowledge and beliefs in the
benefits of screening, and attitude of gynecologists and
other medical doctors [46, 47] towards BC screening
may be of importance.
Conclusion
The effect of socio-demographic, lifestyle and health fac-
tors and screening behavior other than mammography
on non-attendance to BC screening did not differ between
opportunistic and organized screening in Switzerland and
did not explain the large differences in BC screening
attendance between the two regions. Physicians’ recom-
mendations regarding mammography and/or invitations
to attend organized screening should be investigated as
potential explanations for the lower attendance rate in the
German-speaking region. The negative effect of non-
attendance to cervical and colorectal cancer screening on
BC screening in both regions may reflect women’s nega-
tive beliefs and anxiety. This should also be further
investigated.
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